168 related articles for article (PubMed ID: 20889625)
1. Dyslipidemia in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy.
Brewinski M; Megazzini K; Hance LF; Cruz MC; Pavia-Ruz N; Della Negra M; Ferreira FG; Marques H; Hazra R;
J Trop Pediatr; 2011 Oct; 57(5):324-32. PubMed ID: 20889625
[TBL] [Abstract][Full Text] [Related]
2. Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Aurpibul L; Puthanakit T; Lee B; Mangklabruks A; Sirisanthana T; Sirisanthana V
Antivir Ther; 2007; 12(8):1247-54. PubMed ID: 18240864
[TBL] [Abstract][Full Text] [Related]
3. Effects of highly active antiretroviral therapy (HAART) on cholesterol in HIV-1 infected children: a retrospective cohort study.
Kim JY; Zaoutis T; Chu J; Zhao H; Rutstein R
Pharmacoepidemiol Drug Saf; 2009 Jul; 18(7):589-94. PubMed ID: 19402031
[TBL] [Abstract][Full Text] [Related]
4. Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study.
Patroni A; Torti C; Tomasoni L; Quiros Roldan E; Bertelli D; Puoti M; Cadeo GP; Sleiman I; Tinelli C; Carosi G; Castelli F
HIV Clin Trials; 2002; 3(6):451-61. PubMed ID: 12501128
[TBL] [Abstract][Full Text] [Related]
5. Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.
Lainka E; Oezbek S; Falck M; Ndagijimana J; Niehues T
Pediatrics; 2002 Nov; 110(5):e56. PubMed ID: 12415062
[TBL] [Abstract][Full Text] [Related]
6. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
[TBL] [Abstract][Full Text] [Related]
7. Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.
Tassiopoulos K; Williams PL; Seage GR; Crain M; Oleske J; Farley J;
J Acquir Immune Defic Syndr; 2008 Apr; 47(5):607-14. PubMed ID: 18209684
[TBL] [Abstract][Full Text] [Related]
8. Cumulative effects of hypertriglyceridemia in HIV-infected patients switching from NNRTIs to PI-based antiretroviral therapy.
Zhang Y; Xiao J; Zhang W; Han N; Yang D; Liu W; Zeng H; Han J; Zhao H
J Infect Dev Ctries; 2022 Mar; 16(3):528-536. PubMed ID: 35404860
[TBL] [Abstract][Full Text] [Related]
9. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
11. Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors.
Solórzano Santos F; Gochicoa Rangel LG; Palacios Saucedo G; Vázquez Rosales G; Miranda Novales MG
Arch Med Res; 2006 Jan; 37(1):129-32. PubMed ID: 16314198
[TBL] [Abstract][Full Text] [Related]
12. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
[TBL] [Abstract][Full Text] [Related]
13. Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses.
Chou R; Fu R; Huffman LH; Korthuis PT
Lancet; 2006 Oct; 368(9546):1503-15. PubMed ID: 17071284
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysis.
Carter RJ; Wiener J; Abrams EJ; Farley J; Nesheim S; Palumbo P; Bulterys M;
J Acquir Immune Defic Syndr; 2006 Apr; 41(4):453-60. PubMed ID: 16652053
[TBL] [Abstract][Full Text] [Related]
15. Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients.
Tomazic J; Silic A; Karner P; Vidmar L; Maticic M; Poljak M; Ihan A; Janez A
Wien Klin Wochenschr; 2004 Nov; 116(21-22):755-9. PubMed ID: 15628647
[TBL] [Abstract][Full Text] [Related]
16. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
[TBL] [Abstract][Full Text] [Related]
17. The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons.
Mehta SH; Moore RD; Thomas DL; Chaisson RE; Sulkowski MS
J Acquir Immune Defic Syndr; 2003 Aug; 33(5):577-84. PubMed ID: 12902801
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil.
Ceccato MG; Bonolo PF; Souza Neto AI; Araújo FS; Freitas MI
Braz J Med Biol Res; 2011 Nov; 44(11):1177-83. PubMed ID: 22052375
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.
Mandal A; Mukherjee A; Lakshmy R; Kabra SK; Lodha R
Indian J Pediatr; 2016 Mar; 83(3):226-31. PubMed ID: 26334860
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99.
Thiébaut R; Dequae-Merchadou L; Ekouevi DK; Mercié P; Malvy D; Neau D; Dabis F;
HIV Med; 2001 Apr; 2(2):84-8. PubMed ID: 11737383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
